Memorial Sloan Kettering Cancer Center (MSK) is proud to announce that Larry Norton, MD, Senior Vice President, Office of the President; Medical Director, Evelyn H. Lauder Breast Center, has been elected to the American Academy of the Arts & Sciences, and Michel Sadelain, MD, PhD, Director of MSK’s Center for Cell Engineering, has been named the recipient of the Outstanding Achievement Award from the American Society of Gene and Cell Therapy (ASGCT).
Larry Norton Elected to 2021 Academy of Arts & Sciences
The American Academy of Arts & Sciences announced that Larry Norton, MD, was elected to the Academy, one of 252 individuals confirmed as part of the 2021 class. He joins a select group of the nation’s most prominent scholars, scientists, writers, and artists as well as civic, business, and philanthropic leaders that already includes 21 past and present MSK faculty members and one Board member.
Dr. Norton is a world-renowned leader in breast cancer treatment and research, recognized for his expertise in the biology and mathematical principles underlying the formation and development of tumors. His research is aimed at developing more effective approaches for cancer diagnosis, treatment, and prevention.
“I am certainly honored by this recognition, by being invited into the company of those so dedicated to the common good,” said Dr. Norton. “But the honor truly belongs to my community of cancer clinicians and investigators who have accomplished so much but who have their eyes set always on the bright horizon of total victory. We will continue to work tirelessly toward that goal.”
Among his many accomplishments is a mathematics-based approach to therapy, including dose density, which maximizes the ability of cancer drugs to kill tumor cells while minimizing their toxicity. In addition, Dr. Norton was instrumental in the development of several widely used cancer drugs, including paclitaxel (Taxol®) and trastuzumab (Herceptin®).
Election to the Academy of Arts & Sciences is one of the most significant honors anyone can earn. Founded in 1780 by John Adams, John Hancock, and 60 other scholar-patriots, the Academy was created with the recognition that a new nation would require institutions and individuals committed to advancing knowledge in service to the public good.
Michel Sadelain Named Recipient of Outstanding Achievement Award by American Society of Gene and Cell Therapy for CAR T Cells
Michel Sadelain, MD, PhD, Director of MSK’s Center for Cell Engineering, has been named the recipient of the Outstanding Achievement Award from the American Society of Gene and Cell Therapy (ASGCT) for his seminal research on chimeric antigen receptors (CARs).
The Outstanding Achievement Award recognizes an ASGCT Member who has achieved a pioneering research success, specific high-impact accomplishment, or lifetime of significant contributions to the field of gene and cell therapy. It is the Society’s highest honor. Dr. Sadelain will be recognized at this year’s Annual Meeting where he will present a plenary lecture highlighting his scientific accomplishments that led to this award.
“I am delighted and honored to have been selected as a recipient of this very prestigious award from the ASGCT,” said Dr. Sadelain. “The ASGCT has a long-standing commitment to support the basic science and clinical translation of gene and cell therapies, from genetic disorders to mRNA-based vaccines. This award celebrates the transformative nature of T cell engineering and chimeric antigen receptor (CAR) therapy. I look forward to presenting my work, from its origins to current endeavors, at the upcoming plenary lecture on May 13.”
The ASCGT Annual Meeting will be held virtually May 11-14.